Browsing by Author "a0ba7a80-d6f8-4da9-b998-5e278af43182"

Now showing items 1-2 of 2

    • Low-versus standard-dose alteplase in patients on prior antiplatelet therapy: the Enchanted trial (enhanced ... 
      Robinson, Thompson G.; Wang, Xia; Arima, Hisatomi; Bath, Philip M.; Billot, Laurent; Broderick, Joseph P.; Demchuk, Andrew M.; Donnan, Geoffery A.; Kim, Jong S.; Lavados Germain, Pablo Manuel; Lee, Tsong Hai; Lindley, Richard I.; Martins, Sheila C. O.; Olavarria, Veronica V.; Pandian, Jeyaraj D.; Parsons, Mark W.; Pontes Neto, Octavio M.; Ricci, Stefano; Sato, Shoichiro; Sharma, Vijay K.; Nguyen, Thang H.; Wang, Ji Guang; Woodward, Mark; Chalmers, John; Anderson, Craig S. (Lippincott Williams & Wilkins, 2017)
      Background and Purpose-Many patients receiving thrombolysis for acute ischemic stroke are on prior antiplatelet therapy (APT), which may increase symptomatic intracerebral hemorrhage risk. In a prespecified subgroup analysis, ...
    • Rationale, design, and progress of the ENhanced Control of Hypertension ANd Thrombolysis strokE stuDy ... 
      Huang, Yining; Sharma, Vijay K.; Robinson, Thompson; Lindley, Richard I.; Chen, Xiaoying; Kim, Jong Sung; Lavados Germain, Pablo Manuel; Olavarría, Verónica; Arima, Hisatomi; Fuentes, Sully; Nguyen, Huy Thang; Lee, Tsong Hai; Parsons, Mark W.; Levi, Christopher; Demchuk, Andrew M. (Blackwell Publishing Ltd, 2015)
      © 2015 World Stroke Organization. Rationale: Controversy exists over the optimal dose of intravenous (iv) recombinant tissue plasminogen activator (rt-PA) and degree of blood pressure (BP) control in acute ischaemic stroke ...